Glucose oxidase-decorated iron oxide nanoparticles with controlled reactive oxygen species generation for synergistic cancer therapy

Read full text
Authors: Thị Ngọc Dung Dương, Van Du Cao, Huong Kim Hoang, Hoang Duy Nguyen, Nguyen Huy Du, Hai Khoa Le, Quang Anh Tu, Hang Le Dang, Phuong Thi Le
Cited by: 1
References: 24

Abstract

Abstract Magnetic iron oxide nanoparticles (Fe 3 O 4 NPs) have been widely functionalized with various biomolecules to enable targeted and synergistic cancer therapies, employing approaches such as coordination chemistry, polymer coatings, and linker molecules for surface modification. In this study, we developed a simple and effective strategy to functionalize Fe 3 O 4 NPs with glucose oxidase (GO x ) through tannic acid (TA)-mediated surface modification, resulting in Fe 3 O 4 -TA@GO x nanocomposites. The structural and morphological characteristics of the nanosystem were systematically analyzed using UVVis spectrophotometry, Fourier-transform infrared spectroscopy, x-ray diffraction, scanning electron microscopy, and transmission electron microscopy. The Fe 3 O 4 -TA@GO x NPs were shown to generate hydrogen peroxide (H 2 O 2 ) via GO x -catalyzed glucose oxidation, which was subsequently converted into highly reactive hydroxyl radicals ( • OH) through Fenton-like reactions mediated by Fe ions, thereby inducing potent anticancer effects. The selective cytotoxicity of the nanocomposites was evaluated on both normal fibroblast cells (L929) and breast cancer cells (MCF-7), demonstrating the preferential toxicity toward cancer cells. These findings highlighted the potential of Fe 3 O 4 -TA@GO x NPs as a multifunctional nanoplatform for enhanced cancer therapy by integrating chemotherapy, reactive oxygen species (ROS)-based treatment, and starvation therapy.

Fields of Study & Subjects

Advanced Nanomaterials in Catalysis Nanoplatforms for cancer theranostics Nanoparticle-Based Drug Delivery

Publication details

Journal / source
Advances in Natural Sciences Nanoscience and Nanotechnology
Publisher
IOP Publishing
Volume
17
Issue
2
Pages
025008–025008
Publication date
27 May 2026